PatientsVille.com Logo

PatientsVille

Arsenic Side Effects

Common Arsenic Side Effects

The most commonly reported Arsenic side effects (click to view or check a box to report):

Hypotension (11)
Platelet Count Decreased (10)
Haemoglobin Decreased (10)
White Blood Cell Count Decreased (9)
Disseminated Intravascular Coagulation (8)
Dyspnoea (8)
Pyrexia (8)
Electrocardiogram Qt Prolonged (8)
Pneumonia (7)
Asthenia (7)
Alanine Aminotransferase Increased (7)
Blood Lactate Dehydrogenase Increased (6)
Cardiac Failure (6)
Cerebral Haemorrhage (6)
Nausea (5)
Convulsion (5)
Anaemia (5)
Bronchopneumonia (5)
Pleural Effusion (4)
Fluid Overload (4)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Arsenic Side Effects Reported to FDA

The following Arsenic reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Arsenic on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

on Mar 13, 2013 Patient from US , 76 years of age, weighting 171.7 lb, was diagnosed with and was treated with Arsenic Trioxide. . Arsenic Trioxide dosage: 19.5 Bi Weekly Iv. Patient was hospitalized.

Dyspnoea
Patient was taking Arsenic Trioxide. Patient felt the following Arsenic side effects: dyspnoea on Feb 21, 2013 from US Additional patient health information: Patient , 76 years of age, weighting 171.7 lb, was diagnosed with and. Arsenic Trioxide dosage: Bi Weekly. Patient was hospitalized.

Tubulointerstitial Nephritis, Peritonitis
Adverse event was reported on Feb 13, 2013 by a Male taking Arsenic Trioxide (Dosage: N/A) was diagnosed with and. Location: JP , 76 years of age, After Arsenic was administered, patient encountered several Arsenic side effects: tubulointerstitial nephritis, peritonitis.
Multiple concurrent drugs taken:
  • Vesanoid
  • Vesanoid


Cerebral Haemorrhage
on Jun 20, 2012 Male from ITALY , weighting 154.3 lb, was treated with Arsenic Trioxide. Directly after, patient experienced the unwanted or unexpected Arsenic side effects: cerebral haemorrhage. Arsenic Trioxide dosage: 10 Milligram;.
Associated medications used:
  • Atracurium Besylate (80 Milligram;)
  • Methylprednisolone
  • Hydroxyurea (4 Milligram;)
  • Dexamethasone



Oxygen Saturation Decreased, Dehydration, Bradycardia, Syncope, Renal Failure, Cold Sweat, Hypotension, Amnesia, Headache
on May 14, 2012 Male from UNITED STATES , 56 years of age, weighting 217.8 lb, was diagnosed with and was treated with Arsenic Trioxide. Patient felt the following Arsenic side effects: oxygen saturation decreased, dehydration, bradycardia, syncope, renal failure, cold sweat, hypotension, amnesia, headache. Arsenic Trioxide dosage: 18.2347 Mg Bid Weekly X 7 Wks Iv.
Multiple prescriptions taken:
  • 1-lidoderm Patch
  • 4-lexapro
  • 3-norco
  • Keppra
  • 5-celexa
  • Temozolomide (420 Mg Daily X5 Q 28days Po)
Patient was hospitalized.

Hepatotoxicity
Patient was taking Arsenic Trioxide. After Arsenic was administered, patient encountered several Arsenic side effects: hepatotoxicity on Apr 24, 2012 from ITALY Additional patient health information: Male , weighting 160.9 lb, . Arsenic Trioxide dosage: N/A.
Multiple concurrent drugs taken:
  • Transretinoic Acid
Patient was hospitalized.

Asthenia, Myocardial Infarction, Paraesthesia, Alopecia
Adverse event was reported on Feb 16, 2012 by a Male taking Arsenicum Album (Dosage: 10 Other) . Location: ITALY , 59 years of age, Directly after, patient experienced the unwanted or unexpected Arsenic side effects: asthenia, myocardial infarction, paraesthesia, alopecia.
Associated medications used:
  • Doxorubicin Hcl (80 Milligram)
  • Sulfur (10 Drops)
  • Abraxane
  • T-melatonine (2 Tablet)
  • Madopar
  • Xanax (.25 Milligram)
  • Lenicalm (2 Tablet)
  • Seda K (20 Drops)


Condition Aggravated, Obsessive Thoughts, Electrocardiogram Qt Prolonged, Tremor, Anxiety, Laboratory Test Interference, Staphylococcus Test Positive, Agitation
on Dec 29, 2011 Male from UNITED STATES , 43 years of age, was diagnosed with and was treated with Arsenic Trioxide. Patient felt the following Arsenic side effects: condition aggravated, obsessive thoughts, electrocardiogram qt prolonged, tremor, anxiety, laboratory test interference, staphylococcus test positive, agitation. Arsenic Trioxide dosage: 0.15 Mg/kg;iv.
Multiple prescriptions taken:
  • Daunorubicin Hcl
  • Calcium Acetate
  • Fluticasone Propionate
  • Lorazepam
  • Allopurinol
  • Albuterol Sulfate And Ipratropium Bromide
  • Oxycodone Hcl
  • Verapamil
Patient was hospitalized.

Tremor, Depression, Electrocardiogram Qt Prolonged, Hyperhidrosis, Anxiety, Chills, Obsessive Thoughts
on Dec 17, 2011 Male from UNITED STATES , 43 years of age, was treated with Arsenic Trioxide. After Arsenic was administered, patient encountered several Arsenic side effects: tremor, depression, electrocardiogram qt prolonged, hyperhidrosis, anxiety, chills, obsessive thoughts. Arsenic Trioxide dosage: 0.15 Mg/kg;iv.
Multiple concurrent drugs taken:
  • Fluvoxamine Maleate (100 Mg;am)
  • Fluconazole
Patient was hospitalized.

Antiphospholipid Syndrome, Dyspnoea, Pneumonia
Patient was taking Arsenic Trioxide. Directly after, patient experienced the unwanted or unexpected Arsenic side effects: antiphospholipid syndrome, dyspnoea, pneumonia on Dec 14, 2011 from UNITED STATES Additional patient health information: Male , 73 years of age, weighting 205.0 lb, was diagnosed with and. Arsenic Trioxide dosage: 30mg 4 Days A Week Iv. Patient was hospitalized.


Adverse event was reported on Dec 06, 2011 by a Male taking Arsenic Trioxide (Dosage: 15 Mg Twice A Week) . Location: UNITED STATES , 72 years of age, .

Neoplasm Progression, Confusional State, Pyrexia, Hypotension, Neutropenia
on Nov 29, 2011 Female from UNITED STATES , 51 years of age, weighting 119.0 lb, was treated with Arsenic Trioxide. After Arsenic was administered, patient encountered several Arsenic side effects: neoplasm progression, confusional state, pyrexia, hypotension, neutropenia. Arsenic Trioxide dosage: 19.2 Mg.
Multiple concurrent drugs taken:
  • Hydrochlorothiazide
  • Oxycodone Hcl
  • Pantoprazole
  • Valsartan
  • Clonazepam
  • Docusate
Patient was hospitalized.

Herpes Zoster
on Nov 09, 2011 Male from UNITED STATES , 72 years of age, weighting 131.2 lb, was diagnosed with and was treated with Arsenic Trioxide. Directly after, patient experienced the unwanted or unexpected Arsenic side effects: herpes zoster. Arsenic Trioxide dosage: 15mg Twice A Wk Iv. Patient was hospitalized.

Asthenia, Pleural Effusion
Patient was taking Arsenic Trioxide. Patient felt the following Arsenic side effects: asthenia, pleural effusion on Nov 09, 2011 from UNITED STATES Additional patient health information: Male , 72 years of age, weighting 131.2 lb, was diagnosed with and. Arsenic Trioxide dosage: 15mg Twice A Week Iv. Patient was hospitalized.

Gait Disturbance, Amnesia
Adverse event was reported on Nov 04, 2011 by a Female taking Arsenic Trioxide (Dosage: 0.25 Mg Twice A Week) was diagnosed with and. Location: UNITED STATES , 51 years of age, weighting 133.4 lb, After Arsenic was administered, patient encountered several Arsenic side effects: gait disturbance, amnesia.
Multiple concurrent drugs taken:
  • See Attached
Patient was hospitalized.

Hospitalisation
on Nov 02, 2011 Male from UNITED STATES , 72 years of age, weighting 131.2 lb, was diagnosed with and was treated with Arsenic Trioxide. Directly after, patient experienced the unwanted or unexpected Arsenic side effects: hospitalisation. Arsenic Trioxide dosage: 15mg Twice A Week Iv. Patient was hospitalized.

Neutropenia
on Oct 10, 2011 Male from ITALY , 52 years of age, was diagnosed with and was treated with Arsenic Trioxide. Patient felt the following Arsenic side effects: neutropenia. Arsenic Trioxide dosage: 5 Courses Of Monthly Administration.
Multiple prescriptions taken:
  • Tretinoin (8 Courses Of Bi-weekly Administration)


Hyperbilirubinaemia, Disease Progression
Patient was taking Arsenic Trioxide. After Arsenic was administered, patient encountered several Arsenic side effects: hyperbilirubinaemia, disease progression on Oct 11, 2011 from UNITED STATES Additional patient health information: Female , 59 years of age, weighting 188.9 lb, . Arsenic Trioxide dosage: 28.7mg Iv Twice A Week.

Biliary Dilatation, Bile Duct Obstruction, Blood Bilirubin Increased, Metastases To Liver
Adverse event was reported on Oct 05, 2011 by a Female taking Arsenic Trioxide (Dosage: 28.7mg Iv Twice A Week) was diagnosed with and. Location: UNITED STATES , 59 years of age, weighting 188.9 lb, Directly after, patient experienced the unwanted or unexpected Arsenic side effects: biliary dilatation, bile duct obstruction, blood bilirubin increased, metastases to liver. Patient was hospitalized.

Bacteraemia, Sepsis, Respiratory Failure
on Aug 24, 2011 Male from UNITED STATES , weighting 205.0 lb, was diagnosed with and was treated with Arsenic Trioxide. Patient felt the following Arsenic side effects: bacteraemia, sepsis, respiratory failure. Arsenic Trioxide dosage: N/A. Patient was hospitalized.

Mitochondrial Myopathy
on May 30, 2011 Female from FRANCE , 65 years of age, was diagnosed with and was treated with Arsenic Trioxide. After Arsenic was administered, patient encountered several Arsenic side effects: mitochondrial myopathy. Arsenic Trioxide dosage: N/A.

Cerebral Infarction, Leukostasis, Leukocytosis, Disseminated Intravascular Coagulation
Patient was taking Arsenic Trioxide. Directly after, patient experienced the unwanted or unexpected Arsenic side effects: cerebral infarction, leukostasis, leukocytosis, disseminated intravascular coagulation on May 31, 2011 from UNITED STATES Additional patient health information: Female , 27 years of age, was diagnosed with and. Arsenic Trioxide dosage: N/A. Patient was hospitalized.

Neoplasm Malignant, Bone Marrow Disorder, Lung Infection
Adverse event was reported on Mar 31, 2011 by a Male taking Arsenic (Dosage: Unk) was diagnosed with and. Location: GERMANY , 53 years of age, Patient felt the following Arsenic side effects: neoplasm malignant, bone marrow disorder, lung infection.
Multiple prescriptions taken:
  • Bortezomib (Unk)
  • Chlorambucil (Unk)
  • Doxorubicin (Unk)
  • Cyclophosphamide (Unk)
  • Prednisone (Unk)
  • Etoposide (Unk)
  • Ifosfamide (Unk)
  • Carboplatin (Unk)


Electrocardiogram Qt Prolonged
on Jun 24, 2009 Female from UNITED STATES , 55 years of age, weighting 196.2 lb, was treated with Arsenic Trioxide. After Arsenic was administered, patient encountered several Arsenic side effects: electrocardiogram qt prolonged. Arsenic Trioxide dosage: 15mg/kg/dose Iv Daily.
Multiple concurrent drugs taken:
  • Methadone (30mg Po Q12h)
  • Prochlorperazine
  • Hydromorphone
  • Oxybutynin Chloride
  • Temazepam
  • Baclofen
  • Lorazepam
  • Quinapril


Abdominal Pain Upper, Dehydration, Nausea, Vomiting
on Feb 19, 2009 Female from UNITED STATES , 63 years of age, weighting 142.0 lb, was diagnosed with and was treated with Arsenic Trioxide. Directly after, patient experienced the unwanted or unexpected Arsenic side effects: abdominal pain upper, dehydration, nausea, vomiting. Arsenic Trioxide dosage: 15.9 Mg Qd Intravenous.
Associated medications used:
  • Ara-c
  • Pantoprazole Sodium
  • Metformin Hcl
  • Enalapril
  • Ciprofloxacin
Patient was hospitalized.

1 of 5 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Arsenic Side Effects

    Did You Have a Arsenic Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Arsenic for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    Alternative ARSENIC Names:ACNE ADDASECT ANIMAL ANTIGENS ANX ANX HP ANXIETY ANXIETY HP ANXIOLIX ASTH ASTHMA ASTHMA HP ASTHMA RX ASTHMA THERAPY BLOOD AND KIDNEY DE CATARACTS CHEMOCLENZ CHILDRENS COUGH AND CHILDRENS EARACHE R CHRON SINO COLD SORES COMPULSIN CONNECTIVE TISSUE CONSTIPATION COUGH COUGH HP DEPRESSION COMPLEX DIARRHEA ECZEMA ECZEMA HP EDOMETRIOSIS FEMALE FIBROIDS FLU-LIKE SYMPTOMS GALLBLADDER LIVER GALLBLADDER LIVER M GUNA-PMS HANG OVER RELIEF HEADACHE COUGH HEART SMALL INTESTI HERPES SORES HOMEOPATHIC ACNE FO HOMEOPATHIC SHINGLE INSOMNIA INSOMNIA HP INSOMNIA PLUS LIVER DETOX LYM D MET-TOX MOLD ANTIGENS MOLD MIX ANTIGENS NAUSEA VOMITING HP NOBACCO REMEDY WATE OSTEOPOROSIS HP PROGENA PSORIASIS RAD HP RESTULEX ROSACEA SCIATIC AIDE SINUCHRON SINUCHRON HP SINUS RESCUE SINUSITIS SKIN IRRITATION SLEEP RELIEF SMOKE-X STOMACH DISTRESS STOMACH FLU FIGHTER STOMACH SPLEEN MERI TOBACCO WITHDRAWAL TOTAL FLU-CLD 1 TRISENOX V V HP VIRAL HP VIRAL PLUS VIREX VITAL HP VITILIGO WEIGHT MANAGEMENT H WHEEZING HP

    Active Ingredient: ACONITUM ACTIVATED ALLYLTHIO ALTERNARI ANAMIRTA ANAS PLAT APIS MELL ARABICA C ARSENIC ARSENIC T

    More About Arsenic

    Side Effects reported to FDA: 113

    Arsenic safety alerts: 2001

    Reported deaths: 29

    Reported hospitalizations: 75

    Arsenic trioxide

    Healthcare providers reminded to closely monitor patients on arsenic trioxide

    CTI has issued a "Dear Health Care Provider" letter reminding clinicians that QTc prolongation with torsade de pointes arrhythmia and sudden death have been associated with the use of arsenic trioxide. An article published recently in Blood (Unnikrishnan, et al, 1 March 2001;97:1514‚??1516) describes prolonged QT interval and torsade de pointes in 3 patients being treated with arsenic trioxide for acute myeloid leukemia (AML). The arsenic trioxide used in the reported study was not Cell Therapeutics‚?? Trisenox‚?Ę (arsenic trioxide) injection. The current Trisenox label emphasizes the importance of ECG and electrolyte monitoring prior to and during therapy in patients given arsenic trioxide.

    [March 19, 2001 - Letter - Cell Therapeutics, Inc.]

    Latest Arsenic clinical trials

    Arsenic Reviews

    No reviews, be a first to report a side effect via side effect reporting form